ALEXIS OLSON: Open Payments
NPI 1396352860 · IMPERIAL, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,654 in 96 payments from 12 companies in 2025. Trend: 2023 $1,571 · 2024 $1,648 · 2025 $1,654
Food & beverage: $1,654
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $632 |
| Novo Nordisk Inc | 18 | $206 |
| Corcept Therapeutics | 4 | $203 |
| AstraZeneca Pharmaceuticals LP | 9 | $159 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $151 |
| Exact Sciences Corporation | 5 | $92 |
| Lilly USA, LLC | 2 | $62 |
| Amgen Inc. | 3 | $50 |
| PFIZER INC. | 2 | $41 |
| Dynavax Technologies Corporation | 1 | $22 |
Products named: QULIPTA, Korlym, UBRELVY, VRAYLAR, CAPLYTA, AIRSUPRA, Ozempic, The Cologuard Plus Collection Kit.
Industry payments across MO — which companies pay providers there.
